Cabela's Reaches New 52-Week High (CAB)

NEW YORK ( TheStreet) -- Cabela's (NYSE: CAB) hit a new 52-week high Wednesday as it is currently trading at $39.86, above its previous 52-week high of $39.80 with 343,208 shares traded as of 1 p.m. ET. Average volume has been 719,700 shares over the past 30 days.

Cabela's has a market cap of $2.66 billion and is part of the services sector and specialty retail industry. Shares are up 51.2% year to date as of the close of trading on Tuesday.

Cabela's Incorporated, together with its subsidiaries, operates as a specialty retailer and direct marketer of hunting, fishing, camping, and related outdoor merchandise. The company has a P/E ratio of 19.3, equal to the average specialty retail industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Cabela's as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated. You can view the full Cabela's Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus